# Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.

> **NCT05356091** · NA · COMPLETED · sponsor: **Kangbuk Samsung Hospital** · enrollment: 36 (actual)

## Conditions studied

- Quality of Recovery

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT05356091
- **Lead sponsor:** Kangbuk Samsung Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-02
- **Primary completion:** 2023-02-24
- **Final completion:** 2023-02-24
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05356091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05356091, "Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05356091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*